Disclaimer: This article is for informational purposes only and does not constitute medical advice.
- Up to 60% of people with thyroid disease are unaware of their condition, according to the American Thyroid Association — making it one of the most commonly missed diagnoses in medicine.
- A 2026 study published in JAMA Network Open estimated that 72% to 94% of papillary thyroid cancer cases diagnosed between 1991 and 2019 may have been overdiagnosed.
- Hypothyroidism symptoms overlap significantly with depression, menopause, chronic fatigue, and aging — leading to years of misattribution before the correct diagnosis is made.
- Second-opinion pathology review of indeterminate thyroid biopsies avoided unnecessary surgery in 25% of patients, according to Stanford University research.
- Hashimoto’s thyroiditis, the leading cause of hypothyroidism in the US, UK, and Australia, frequently goes undetected because standard thyroid panels often omit thyroid antibody testing.
More than 20 million Americans are living with some form of thyroid disease — yet according to the American Thyroid Association (ATA), up to 60% of them don’t know it. That statistic represents millions of people walking around with fatigue they blame on stress, weight gain they attribute to aging, and brain fog they chalk up to poor sleep — never suspecting that a butterfly-shaped gland at the base of their throat is the real culprit.
Thyroid misdiagnosis takes two equally dangerous forms. On one side, conditions like hypothyroidism and Hashimoto’s thyroiditis go undetected for years while patients receive treatment for depression, anxiety, or menopause symptoms that never seem to improve. On the other, thyroid cancer overdiagnosis has led to tens of thousands of unnecessary surgeries and treatments for tumors that would never have caused harm. Both scenarios underscore why thyroid conditions demand careful, informed medical evaluation — and why seeking a second opinion can be life-changing.
This comprehensive guide examines how and why thyroid misdiagnosis happens, which conditions are most commonly confused with thyroid disorders, and the specific steps you can take to protect yourself or someone you love.
What Is Thyroid Misdiagnosis? Understanding the Scope of the Problem
Thyroid misdiagnosis occurs when a thyroid disorder is either incorrectly identified, overlooked entirely, or diagnosed when no clinically significant disease is present. It encompasses missed diagnoses (failing to identify hypothyroidism or thyroid cancer), wrong diagnoses (attributing thyroid symptoms to another condition), and overdiagnosis (detecting and treating thyroid abnormalities that would never have caused symptoms or harm).
The thyroid gland produces hormones — primarily thyroxine (T4) and triiodothyronine (T3) — that regulate metabolism, heart rate, body temperature, and energy levels in virtually every cell of the body. When thyroid function is disrupted, the effects are widespread and often mimic other conditions, which is precisely what makes misdiagnosis so common.
According to a 2014 systematic review by Garmendia Madariaga and colleagues, published in the Journal of Clinical Endocrinology & Metabolism, the prevalence of undiagnosed hypothyroidism across 19 studies involving more than 100,000 participants was approximately 4.94%. Extrapolated to the populations of the United States, United Kingdom, and Australia, this suggests millions of people in these countries alone are living with undetected underactive thyroid function.
The consequences of missed thyroid disease are far from trivial. Untreated hypothyroidism increases the risk of cardiovascular disease, elevated cholesterol, cognitive decline, infertility, and pregnancy complications including miscarriage — with some research suggesting a two to fourfold increase in miscarriage risk for women with overt untreated hypothyroidism. If you suspect your symptoms are being dismissed or misattributed, understanding the common signs of misdiagnosis is an essential first step.
Hypothyroidism Misdiagnosis: Why It’s So Often Missed
Hypothyroidism — an underactive thyroid gland that produces insufficient thyroid hormone — is one of the most frequently missed diagnoses in primary care. The core challenge is that its symptoms are non-specific, gradual in onset, and overlap extensively with other common conditions.
The classic symptoms of hypothyroidism include persistent fatigue and low energy, unexplained weight gain or difficulty losing weight, cold intolerance, constipation, dry skin and hair, hair loss, muscle aches and joint pain, brain fog and difficulty concentrating, depressed mood, and menstrual irregularities. Every single one of these symptoms is also associated with depression, perimenopause, chronic stress, iron deficiency anemia, sleep disorders, and normal aging — creating a diagnostic minefield for clinicians who may not think to order thyroid function tests.
A 2023 study published in Cureus by Yadav, Kose, and Bhalerao found that among 150 women over age 40, hypothyroidism and subclinical hypothyroidism affected 13.3% and 23.3% of the study population respectively. Notably, depressive mood was found in 20% of hypothyroid women compared to just 2.5% of euthyroid women (p=0.003), illustrating how thyroid dysfunction directly produces psychiatric symptoms that may be treated with antidepressants rather than thyroid hormone replacement.
The problem is compounded by several systemic factors. Many general practitioners rely solely on TSH (thyroid-stimulating hormone) testing, which may miss cases where TSH is in the “normal” range but a patient is symptomatic — particularly in the controversial subclinical hypothyroidism zone where TSH is mildly elevated but free T4 remains normal. Some clinicians use broad reference ranges that may not account for age, sex, or individual variation. And in the United Kingdom’s NHS system, patients frequently report that their thyroid concerns are dismissed before testing is even ordered. If your doctor has attributed your symptoms to anxiety or stress and you feel unheard, our guide on what to do when your doctor says it’s anxiety but it’s not can help you advocate for proper testing.
Who Is Most at Risk for Missed Hypothyroidism?
Certain populations face a disproportionately higher risk of having hypothyroidism go undetected. Women are five to eight times more likely than men to develop thyroid disease, with approximately 1 in 8 women developing a thyroid disorder during her lifetime, according to the ATA. Despite this, routine screening remains inconsistent — the US Preventive Services Task Force (USPSTF) concluded in 2015 that there is insufficient evidence to recommend for or against routine thyroid screening in asymptomatic, non-pregnant adults.
Older adults are particularly vulnerable because hypothyroidism symptoms in this population — fatigue, cognitive slowing, constipation, cold intolerance — closely mirror what many clinicians simply attribute to aging. Postpartum women face their own risk: postpartum thyroiditis affects 5% to 10% of women, and approximately 25% to 30% of those affected progress to permanent hypothyroidism within five to ten years.
People with a family history of thyroid or autoimmune disease, those who have undergone head or neck radiation, and individuals with existing autoimmune conditions such as type 1 diabetes, celiac disease, or rheumatoid arthritis are also at elevated risk. Yet without a systematic approach to screening these high-risk groups, many cases continue to slip through the diagnostic net.
Hashimoto’s Thyroiditis: The Autoimmune Condition Hiding in Plain Sight
Hashimoto’s thyroiditis is an autoimmune disorder in which the immune system attacks the thyroid gland, gradually destroying its ability to produce hormones. It is the most common cause of hypothyroidism in iodine-sufficient countries including the United States, United Kingdom, and Australia, affecting roughly 1% to 2% of the general population — though the true prevalence is likely higher because many cases are never diagnosed.
What makes Hashimoto’s particularly prone to misdiagnosis is its insidious progression. The autoimmune attack can unfold over years or even decades before the thyroid gland is sufficiently damaged to produce abnormal TSH levels on standard blood work. During this long preclinical phase, patients may experience fluctuating symptoms — periods of hypothyroid symptoms alternating with episodes of hyperthyroid-like symptoms (known as “Hashitoxicosis”) when damaged thyroid cells release stored hormone — creating a confusing clinical picture that defies easy categorization.
Data from the landmark NHANES III study (Hollowell et al., Journal of Clinical Endocrinology & Metabolism, 2002) revealed that thyroid peroxidase (TPO) antibodies — the hallmark of Hashimoto’s — were present in 11.3% of US women, a figure far exceeding the number who had been clinically diagnosed. Research suggests that approximately 2% to 4% of women with positive TPO antibodies progress to overt hypothyroidism each year, meaning many are walking around with active autoimmune thyroid destruction that standard TSH screening alone will not detect.
The diagnostic gap exists because many healthcare providers do not routinely test for thyroid antibodies (TPO antibodies and thyroglobulin antibodies). A patient with early-stage Hashimoto’s may have a normal TSH, normal free T4, and a constellation of symptoms — fatigue, joint pain, anxiety, brain fog — that gets attributed to fibromyalgia, chronic fatigue syndrome, depression, or perimenopause. This pattern of autoimmune disease misdiagnosis is alarmingly common across all autoimmune conditions, not just thyroid disorders.
| Feature | Hashimoto’s Thyroiditis | Non-Autoimmune Hypothyroidism |
|---|---|---|
| Cause | Autoimmune attack on thyroid | Iodine deficiency, surgery, radiation, medication |
| Antibody Test | TPO and/or TG antibodies positive | Antibodies typically negative |
| Progression | Gradual, may fluctuate for years | Depends on cause; may be sudden (post-surgery) |
| Associated Risks | Other autoimmune conditions, thyroid lymphoma | Depends on underlying cause |
| Management | Thyroid hormone + autoimmune monitoring | Thyroid hormone + address root cause |
Thyroid Cancer: The Overdiagnosis Epidemic
While hypothyroidism and Hashimoto’s are frequently underdiagnosed, thyroid cancer presents the opposite problem: widespread overdiagnosis that has led to an epidemic of unnecessary treatment. A landmark 2026 modelling study by Francis et al., published in JAMA Network Open, estimated that between 72% and 94% of papillary thyroid cancer (PTC) cases diagnosed in US adults from 1991 to 2019 represented overdiagnosis — meaning these cancers would never have caused symptoms, harm, or death during the patient’s lifetime.
The numbers are striking. According to the American Cancer Society’s Cancer Facts & Figures 2026, an estimated 45,240 new cases of thyroid cancer will be diagnosed in the United States this year, with approximately 32,000 occurring in women. Yet only about 2,320 people will die from the disease. The five-year relative survival rate for thyroid cancer exceeds 98%, reflecting the generally indolent nature of the most common subtype, papillary thyroid carcinoma.
US thyroid cancer incidence rose approximately 250% since 1990, driven largely by the proliferation of imaging technology — CT scans, MRIs, and neck ultrasounds performed for unrelated reasons that incidentally detect tiny thyroid nodules. The Francis et al. study estimated that reducing thyroid ultrasonography for non-palpable nodules by just 33% would have lowered papillary thyroid cancer incidence in 2019 by 17%, with negligible change in overall mortality. A 67% reduction in such imaging would have cut incidence by 41%.
The human cost of overdiagnosis is substantial. Patients diagnosed with thyroid “cancer” — even indolent microcarcinomas that may never cause problems — frequently undergo total thyroidectomy, radioactive iodine therapy, and lifelong thyroid hormone replacement. These treatments carry real risks including surgical complications (vocal cord damage, hypoparathyroidism), the anxiety and psychological burden of a cancer diagnosis, and the ongoing management challenges of synthetic thyroid hormone therapy. For a deeper understanding of why cancer pathology reviews matter, see our guide on getting a second opinion on cancer pathology.
When Thyroid Cancer Is Genuinely Missed
While overdiagnosis dominates the thyroid cancer landscape, genuine underdiagnosis also occurs — particularly with aggressive thyroid cancer subtypes. Anaplastic thyroid cancer, medullary thyroid cancer, and poorly differentiated thyroid cancer are far less common than papillary thyroid cancer but carry significantly worse prognoses and may initially be mistaken for benign thyroid conditions.
Fine-needle aspiration (FNA) biopsy, the standard diagnostic tool for evaluating thyroid nodules, has meaningful limitations. A study by Agcaoglu et al., published in the International Journal of Endocrinology (2013), reported an overall FNA false-negative rate of 11% — meaning that 1 in 9 malignant nodules was initially classified as benign. The study found that the presence of a cytopathologist during the biopsy procedure dramatically affected accuracy: the false-negative rate was approximately 1.1% when a cytopathologist was present but rose to an alarming 43.9% when one was not.
Nodule size also affected results, with nodules between 2 and 4 centimeters carrying approximately five times higher odds of a false-negative result compared to smaller nodules. These findings underscore the importance of ensuring that thyroid biopsies are performed by experienced practitioners at facilities with dedicated cytopathology expertise.
The Power of a Second Opinion in Thyroid Diagnosis
For thyroid conditions — where both underdiagnosis and overdiagnosis are rampant — seeking a second opinion is not merely reasonable but often essential. Research from Stanford University illustrates this clearly.
In a retrospective study published in Surgery (2010), Davidov and colleagues reviewed 331 thyroid FNA biopsies sent from outside centres to Stanford for second-opinion cytopathology review. Overall concordance with the original reading was just 66%. For indeterminate biopsies — the grey-zone results that most commonly lead to diagnostic surgery — concordance dropped to only 37%. Of these indeterminate cases, 21% were reclassified as non-diagnostic and 42% as benign on second review. Most importantly, second-opinion review avoided unnecessary diagnostic thyroidectomy in 25% of patients with indeterminate results, while FNA diagnostic accuracy improved from 60% to 74%.
These findings mean that for every four patients facing surgery based on an indeterminate thyroid biopsy, one could potentially avoid the operating table entirely through expert second-opinion review — without any increase in missed cancers.
- You’ve been diagnosed with thyroid cancer and surgery has been recommended
- An FNA biopsy returned indeterminate or suspicious results
- You’ve been told your thyroid labs are “normal” but your symptoms persist
- You’ve been treated for hypothyroidism but continue to feel unwell
- Your symptoms were attributed to depression, menopause, or aging without thyroid testing
- You have a family history of thyroid disease but have never been formally screened
- A thyroid nodule has been identified and you’re unsure whether to watch or treat
For practical guidance on gathering the documentation you’ll need, our step-by-step guide on how to request your medical records walks you through the process. And if you’re considering a remote consultation, our guide to online medical second opinions covers the best platforms and what to expect.
Conditions Commonly Confused With Thyroid Disorders
One of the primary reasons thyroid conditions go undetected is the extensive symptom overlap with other conditions. Understanding these diagnostic mimics can help you and your healthcare provider consider thyroid testing when it might otherwise be overlooked.
Depression and Anxiety Disorders: Hypothyroidism can cause depressed mood, anxiety, irritability, and cognitive impairment that is virtually indistinguishable from major depressive disorder without blood work. Studies estimate that thyroid dysfunction is present in 1% to 4% of patients diagnosed with depression, and some experts believe this figure underestimates the true overlap, particularly for subclinical hypothyroidism.
Perimenopause and Menopause: For women in their 40s and 50s — the very age when thyroid disease incidence peaks — the symptoms of falling estrogen and declining thyroid function are nearly identical: hot flushes, mood swings, weight gain, fatigue, sleep disturbances, and irregular periods. Unless thyroid testing is performed, one condition may be mistaken for the other for years.
Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia: Both conditions share symptoms of debilitating fatigue, muscle pain, cognitive dysfunction, and sleep disturbance with hypothyroidism. Importantly, thyroid disease is a condition that should be ruled out before either diagnosis is made — yet this step is sometimes missed or incomplete, particularly when only TSH is tested.
Iron Deficiency Anemia: Fatigue, weakness, cold intolerance, pale skin, and brittle nails are common to both conditions. Iron deficiency and hypothyroidism can also coexist, with some research suggesting that hypothyroidism impairs iron absorption.
Sleep Apnea: Both hypothyroidism and obstructive sleep apnea cause daytime fatigue, cognitive impairment, and weight gain. Hypothyroidism can actually contribute to sleep apnea through tissue swelling in the upper airway, creating a situation where treating one condition may improve the other.
Type 2 Diabetes and Metabolic Syndrome: Weight gain, fatigue, and elevated cholesterol are shared symptoms. People with type 1 diabetes have an increased risk of autoimmune thyroid disease, but the metabolic overlap between hypothyroidism and type 2 diabetes can also delay correct diagnosis of either condition.
How to Advocate for Proper Thyroid Testing
If you suspect a thyroid disorder is being missed, knowing which tests to ask for — and understanding what the results mean — can help you have a more productive conversation with your healthcare provider.
The Essential Thyroid Panel: A comprehensive thyroid evaluation should include TSH (thyroid-stimulating hormone) as the primary screening test, Free T4 (free thyroxine) to measure available thyroid hormone, Free T3 (free triiodothyronine) for a complete picture of thyroid hormone activity, TPO Antibodies (thyroid peroxidase) to detect Hashimoto’s or autoimmune thyroid disease, and Thyroglobulin Antibodies (TgAb) as another marker of autoimmune thyroid activity.
Many general practitioners order only TSH, and sometimes TSH plus total T4. This limited testing can miss subclinical hypothyroidism, early Hashimoto’s with normal TSH, conversion disorders where T4 is normal but T3 is low, and cases where “normal” TSH falls in a range that is suboptimal for the individual patient.
Understanding TSH Reference Ranges: The standard TSH reference range at most laboratories is approximately 0.4 to 4.0 or 4.5 mIU/L. However, there is ongoing debate in the endocrinology community about whether the upper limit should be lowered. The National Academy of Clinical Biochemistry has suggested that 95% of normal individuals have TSH values below 2.5 mIU/L, and some endocrinologists advocate treating symptomatic patients whose TSH exceeds 2.5, even though this falls within the “normal” range. This controversy means that a patient with a TSH of 3.5 might be told their thyroid is perfectly fine by one doctor and diagnosed with subclinical hypothyroidism by another — making a second opinion particularly valuable.
Thyroid Ultrasound: If nodules are suspected or you have risk factors for thyroid cancer (family history, radiation exposure, or concerning symptoms such as a rapidly growing neck mass, hoarseness, or difficulty swallowing), a thyroid ultrasound can identify structural abnormalities that blood tests alone cannot reveal.
Thyroid Misdiagnosis in Specific Populations
Women and Gender-Based Diagnostic Bias
Women bear a disproportionate burden of thyroid misdiagnosis. Thyroid disease is the most common endocrine disorder in women, yet research consistently shows that women’s health complaints — particularly fatigue, pain, and mood disturbances — are more likely to be attributed to psychological causes than men’s equivalent complaints. This phenomenon of medical gaslighting means that thyroid symptoms in women are more likely to be dismissed as stress, anxiety, or hormonal fluctuations without investigation.
The Francis et al. (2026) overdiagnosis study found that the overdiagnosis rate for papillary thyroid cancer was slightly higher in women (75% to 95%) than men (63% to 90%), meaning women are simultaneously more likely to have genuine thyroid disease missed and more likely to be overdiagnosed and overtreated for thyroid cancer.
Pregnant Women
Thyroid hormone demand increases by approximately 30% to 50% during the first trimester of pregnancy, and undetected hypothyroidism during pregnancy carries serious risks. A landmark study by Haddow et al. (New England Journal of Medicine, 1999) found that children born to mothers with untreated hypothyroidism scored an average of 7 points lower on IQ tests at ages 7 to 9. The American Thyroid Association’s 2017 pregnancy guidelines (Alexander et al., Thyroid) recommend targeting a TSH below 4.0 mIU/L during pregnancy, with many clinicians aiming for below 2.5 in the first trimester.
Older Adults
In patients over 60, hypothyroidism symptoms are routinely attributed to aging. Cognitive slowing is called “normal age-related decline,” constipation is blamed on medications or diet, and fatigue is written off as part of getting older. Yet thyroid disease prevalence increases with age, and untreated hypothyroidism in older adults significantly increases cardiovascular risk and accelerates cognitive decline.
Children and Adolescents
Thyroid disease in young people is often overlooked because clinicians don’t expect it in this age group. Hashimoto’s thyroiditis is the most common cause of acquired hypothyroidism in children and adolescents, potentially affecting growth, academic performance, and puberty timing. Symptoms such as fatigue, weight gain, and poor concentration may be attributed to laziness, screen time, or behavioural problems rather than thyroid dysfunction.
Frequently Asked Questions (FAQ) About Thyroid Misdiagnosis
How common is thyroid misdiagnosis?
Thyroid misdiagnosis is extremely common. The American Thyroid Association estimates that up to 60% of people with thyroid disease are unaware of their condition, meaning they have never been correctly diagnosed. For thyroid cancer specifically, a 2026 study in JAMA Network Open estimated that 72% to 94% of papillary thyroid cancer cases diagnosed in the US between 1991 and 2019 represented overdiagnosis. Both missed diagnoses and overdiagnosis contribute to the scale of the problem.
Can hypothyroidism be mistaken for depression?
Yes, hypothyroidism is frequently mistaken for depression because the two conditions share many symptoms including persistent fatigue, low mood, difficulty concentrating, weight gain, and sleep disturbances. Research suggests that thyroid dysfunction is present in approximately 1% to 4% of patients diagnosed with depression. The American Thyroid Association and many psychiatry guidelines recommend thyroid function testing as part of the evaluation for depression, but this step is not always performed in practice.
What tests should I ask for if I suspect a thyroid problem?
If you suspect a thyroid problem, you should request a comprehensive thyroid panel that includes TSH (thyroid-stimulating hormone), Free T4, Free T3, TPO antibodies (thyroid peroxidase antibodies), and thyroglobulin antibodies. Many physicians order only TSH, which can miss early Hashimoto’s thyroiditis, subclinical hypothyroidism, and T4-to-T3 conversion issues. If nodules are suspected, a thyroid ultrasound should also be performed. Bringing a written list of your symptoms, their duration, and family history of thyroid or autoimmune disease can help ensure your concerns are taken seriously.
How accurate are thyroid biopsies, and should I get a second opinion?
Thyroid fine-needle aspiration (FNA) biopsies have a false-negative rate ranging from approximately 1% to 11% depending on the facility, operator experience, and whether a cytopathologist is present during the procedure. A Stanford University study found that second-opinion pathology review of indeterminate thyroid biopsies changed the diagnosis in 63% of cases and avoided unnecessary surgery in 25% of patients. If your biopsy returned indeterminate, suspicious, or unexpectedly benign results — especially if you have concerning clinical features — a second-opinion pathology review from an academic medical centre or specialist thyroid pathologist is strongly recommended.
Is thyroid cancer overdiagnosed, and how do I know if my diagnosis is accurate?
Research strongly suggests that thyroid cancer — particularly papillary thyroid cancer — is significantly overdiagnosed. A 2026 study published in JAMA Network Open estimated overdiagnosis rates as high as 72% to 94% of cases diagnosed between 1991 and 2019. This does not mean your specific diagnosis is wrong, but it does mean that if you’ve been diagnosed with a small, low-risk papillary thyroid cancer, seeking an expert second opinion from an endocrinologist or thyroid surgeon at a high-volume centre is particularly important. Active surveillance (watchful waiting) is increasingly recognised as a safe alternative to immediate surgery for small, low-risk papillary thyroid microcarcinomas, and an experienced specialist can help you weigh this option.
Taking Action: Next Steps if You Suspect Thyroid Misdiagnosis
If you believe your thyroid condition has been missed or misdiagnosed, there are concrete steps you can take right now to move toward an accurate diagnosis and appropriate treatment.
First, document your symptoms. Create a detailed log of your symptoms, when they started, how they’ve progressed, and any family history of thyroid or autoimmune disease. Include any medications you’ve been prescribed that haven’t helped — this pattern of failed treatments for conditions like depression or chronic fatigue can itself be an important diagnostic clue.
Second, request comprehensive testing. Ask your doctor for a full thyroid panel including TSH, Free T4, Free T3, TPO antibodies, and thyroglobulin antibodies. If your doctor is unwilling to order these tests, that itself may be a reason to seek a second opinion.
Third, seek a specialist evaluation. An endocrinologist — particularly one who specialises in thyroid disorders — will bring deeper expertise than a general practitioner and may interpret borderline results differently. For thyroid cancer concerns, a consultation with a high-volume thyroid surgeon or a specialist at an academic medical centre can provide the most informed assessment.
Fourth, consider a second-opinion pathology review. If you’ve had a thyroid biopsy — particularly one with indeterminate results — having the slides reviewed by a specialist thyroid cytopathologist can change the diagnosis and potentially save you from unnecessary surgery.
Finally, don’t accept persistent symptoms as normal. The average time from symptom onset to hypothyroidism diagnosis has been reported at four to five years in some studies. You don’t have to wait that long. If you’re experiencing persistent fatigue, weight gain, mood changes, or cognitive difficulties that haven’t responded to treatment, advocate firmly for thyroid evaluation — and if your concerns are dismissed, seek a second opinion from a provider who will listen.
Your health depends on accurate diagnosis, and for thyroid conditions — where both missed diagnoses and overdiagnosis are widespread — a second set of expert eyes can make all the difference.